Allakos Inc. (ALLK) Covered Calls
Allakos Inc. operates as a clinical stage biopharmaceutical company. The company is developing antolimab (AK002) for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.
There are no covered calls available for Allakos Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
| Top 10 Open Interest For Jun 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | IWM covered calls | 1. | APP covered calls | |
| 2. | SPY covered calls | 7. | EEM covered calls | 2. | APLD covered calls | |
| 3. | SLV covered calls | 8. | TSLA covered calls | 3. | SFIX covered calls | |
| 4. | QQQ covered calls | 9. | FXI covered calls | 4. | ALT covered calls | |
| 5. | GLD covered calls | 10. | TLT covered calls | 5. | SERV covered calls | |
Want more examples? ALLE Covered Calls | ALLO Covered Calls
